Alert: Pfizer and Flynn Pharma Fined £90 Million for Charging “Excessive Prices” for Epilepsy Medicine

Published date15 December 2016
Law FirmCooley LLP
AuthorBecket McGrath,Jo Love
Subject MatterManufacturers,TFEU,Competition Act,UK,Drug Pricing,UK Competition and Markets Authority (CMA),Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT